Home › Funds › Atle Fund Management AB › SMMT

Atle Fund Management AB position in SMMT

SUMMIT THERAPEUTICS INC · Health Care

Atle Fund Management AB reported holding 184,687 shares of SMMT (SUMMIT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 0.84% of its reported portfolio and ranking #33 among its reported holdings. Atle Fund Management AB has disclosed SMMT holdings in 6 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)184.69K sh
Reported value held$3.12M
Portfolio Weight0.84%
First reportedQ3 2024
Last changeNew
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's SMMT position evolved

Atle Fund Management AB first disclosed a stake in SMMT in Q3 2024 at 86,013 shares (US$1.9M). The position peaked in Q3 2026 at 184,687 shares, worth US$3.1M. Across 6 filings, Atle Fund Management AB increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 184,687 shares valued at US$3.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 86.01K $1.88M New
Q4 2024 101.18K $1.31M Add
Q1 2025 105.08K $2.03M Add
Q2 2025 92.74K $1.97M Reduce
Q3 2025 92.74K $203.40K Hold
Q3 2026 184.69K $3.12M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SMMT and 13F data

SMMT (SUMMIT THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in SMMT — the largest reported positions include BAKER BROS. ADVISORS LP (US$477.7M), Logos Global Management LP (US$19.7M), Octagon Capital Advisors LP (US$18.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SMMT

All SMMT fund holders →

FAQ

How long has Atle Fund Management AB held SMMT?

Atle Fund Management AB has disclosed SMMT holdings in 6 of the last 9 reported quarters, going back to Q3 2024.

What is Atle Fund Management AB's current position in SMMT?

As of Q3 2026, Atle Fund Management AB holds 184.69K shares of SMMT (SUMMIT THERAPEUTICS INC), valued at $3.12M, representing 0.84% of its reported portfolio and ranking #33.

Has Atle Fund Management AB been buying or selling SMMT?

In the latest 13F filing (Q3 2026), Atle Fund Management AB newly opened its position in SMMT. The position peaked in Q3 2026 at 184.69K shares.

Which other funds hold SMMT?

Other major institutional holders of SMMT include BAKER BROS. ADVISORS LP, Logos Global Management LP, Octagon Capital Advisors LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.